← All indications
Ischemia
A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
Subtype terms (3)
More specific conditions that are subtypes of Ischemia in the MeSH hierarchy.
- Chronic Limb-Threatening Ischemia
73 drugs (27 approved, 46 experimental)
- Infarction
4 drugs (3 approved, 1 experimental)
- No-Reflow Phenomenon
13 drugs (11 approved, 2 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (16)
Phase 3 trials (15)
Phase 2 trials (11)
Phase 1 trials (10)
Organizations
Organization Involved with Phase 4 Indications (215)
- General Electric
- Daiichi Sankyo
- Vita-Salute University of Milano. Italy
- Retina Macula Specialists of Miami, LLC
- University of California, San Francisco
- Tsinghua University
- I.M. Sechenov First Moscow State Medical University
- Shanghai Municipal Science and Technology Commission
- Excel PharmaStudies, Inc.
- Tel Aviv University
- Kaohsiung Medical University
- Jilin University
- Icahn School of Medicine at Mount Sinai
- Accumetrics, Inc.
- Ain Shams University
- Clinica Universidad de Navarra
- Xijing Hospital
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Kuang Tien General Hospital
- China Medical University
- Ankara Yildirim Beyazıt University
- Network for Clinical Stroke Trials
- Government of Taiwan
- Otsuka
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Vienna
- Zuyderland Medisch Centrum
- Hunan University of Traditional Chinese Medicine
- Anhui Medical University
- University of Geneva
- +185 more
Organization Involved with Phase 3 Indications (229)
- Linkoping University
- University of Valencia
- University of Alabama, Birmingham
- Bio-Science Laboratories
- Government of Poland
- Hospital Santa Marcelina, Sao Paulo, Brasil
- New York Medical College
- Lankenau Hospital
- University of Iowa
- Roche
- Dexa Laboratories Of Biomolecular Science
- Neurobiological Technologies
- Trillium Health Partners
- University of California, Los Angeles
- St. Louis University
- GWT-TUD GmbH
- Seberang Jaya Clinical Research Centre
- Hospital do Coracao
- AnGes, Inc.
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Cancer Institute (NCI)
- Clinical Centre of Serbia
- Netherlands Organisation for Scientific Research
- National Institutes of Health (NIH)
- United Therapeutics
- Aarhus University
- Chang Gung University
- Centocor
- University of Ostrava
- Stony Brook University
- +199 more
Organization Involved with Phase 2 Indications (196)
- Dompe Pharmaceuticals
- Acticor Biotech
- MedAvante
- University of Cambridge
- Linyi People's Hospital
- Apceth GmbH & Co. KG
- Angde Biotech Pharmaceutical Co., Ltd.
- Soon Chun Hyang University
- RTI International
- Medanta - The Medicity
- Biopure Corporation
- Madras Medical College
- Cord Blood Registry, Inc.
- Salus Pharma
- UKM Medical Centre
- Janssen Pharmaceutica NV
- Venturis Therapeutics
- TCA Cellular Therapy
- Inner Mongolia Baogang Hospital
- Guangzhou Recomgen Biotech Co., Ltd.
- William Beaumont Hospitals
- Melaka Manipal Medical College
- Fibrex Medical Research & Development GmbH
- Shifa Tameer-e-Millat University
- Shijiazhuang Pharma Group (CSPC)
- Bhagwan Mahaveer Jain Hospital
- Medpace, Inc.
- Remedy Pharmaceuticals, Inc.
- Monash University
- Sunovion
- +166 more
Organization Involved with Phase 1 Indications (53)
- University of Dundee
- Meridigen Biotech Co., Ltd.
- Hospital Hernando Moncaleano Perdomo
- Chinese University of Hong Kong
- Nagoya University
- Fraser Health
- National University of Ireland
- CSL Behring
- City University of Hong Kong
- University of Colorado, Denver
- Wyeth
- Seneca Biopharma, Inc.
- Pharmicell Co., Ltd.
- Life Science Institute, Inc.
- Genentech
- Libella Gene Therapeutics
- Translational Sciences, Inc.
- Mononuclear Therapeutics Ltd.
- Government of Singapore
- Gachon University
- Indiana University
- StemCyte, Inc.
- Beytepe Murat Erdi Eker State Hospital
- BHI Therapeutic Sciences
- Dow University of Health Sciences
- Aalborg University
- Thoratec
- University of Kentucky
- Taiwan Bio Therapeutics Co., Ltd.
- BioVision, Inc.
- +23 more
Organization Involved with Other Experimental Indications (56)
- Bethune International Peace Hospital
- University of Pavia
- Newcastle University
- Centro Cardiologico Monzino IRCCS
- University of Montpellier
- AUSL della Romagna-RAVENNA
- Triemli Hospital
- James N. Kirby Foundation
- University of Chile
- ISTITUTO REGINA ELENA
- University of Burgundy
- University of Connecticut
- Medtronic
- Pooyesh Darou
- Universidad Autonoma de Nuevo Leon
- Ankara Universitesi Teknokent
- University of Lausanne
- Vanderbilt University
- University of Bern
- Free University of Brussels
- Thompson Rivers University
- Kyoto Prefectural University of Medicine
- Fondazione G.B. Bietti, IRCCS
- University of South China
- Konkuk University
- Luzerner Kantonsspital
- Institute of Liver and Biliary Sciences, India
- St. John's Research Institute
- University of Oklahoma
- Shangluo Central Hospital
- +26 more